From the Guidelines
Low liver function in end-stage kidney disease is a common complication due to the interconnected mechanisms of kidney and liver failure, where uremic toxins, chronic inflammation, and altered drug metabolism directly impair liver function. The kidneys and liver work closely together, so when kidneys fail, liver function often deteriorates as well. Uremic toxins that accumulate in the bloodstream due to poor kidney filtration directly damage liver cells and impair their function, as seen in patients with end-stage renal disease (ESRD) following liver transplantation (LT) 1. The chronic inflammation present in kidney disease affects the liver through inflammatory mediators that disrupt normal hepatic processes. Patients with end-stage kidney disease frequently experience altered drug metabolism because the liver cannot properly process medications, leading to potential toxicity. Fluid overload and hemodynamic changes from kidney failure strain the liver's blood supply, while malnutrition and reduced protein intake further compromise liver regeneration and function.
Some key factors contributing to low liver function in end-stage kidney disease include:
- Uremic toxins and chronic inflammation
- Altered drug metabolism and potential toxicity
- Fluid overload and hemodynamic changes
- Malnutrition and reduced protein intake
- Comorbidities like diabetes that independently affect both organs
- Hepatitis infections, which are more common in dialysis patients and further damage liver tissue, as discussed in the context of liver transplantation and kidney disease 1.
The relationship between liver and kidney function is critical in managing end-stage kidney disease, and understanding the mechanisms of liver dysfunction can inform strategies to protect and preserve liver function in these patients.
From the Research
Low Liver Function in End-Stage Kidney Disease
- Low liver function in end-stage kidney disease can be attributed to the interconnectedness of renal and liver functions due to splanchnic hemodynamic relationships 2.
- Renal failure rarely occurs in patients without advanced decompensated cirrhosis, suggesting a link between liver disease and kidney function 2.
- The assessment of renal function in patients with end-stage liver disease (ESLD) should include an evaluation of liver function, as renal and hepatic functions are intertwined 2.
Pathophysiology and Consequences
- Renal dysfunction is a frequent complication in patients with end-stage liver disease awaiting orthotopic liver transplantation and in the post-liver transplant period 3.
- The hepatorenal syndrome is a stereotypical form of renal dysfunction in this population, but other causes of acute kidney injury include prerenal azotemia and acute tubular necrosis 3.
- Renal injury in a patient with cirrhosis is associated with a poor prognosis, highlighting the importance of managing renal function in end-stage liver disease 3.
Management and Evaluation
- The evaluation of renal function in cirrhosis should include an assessment of hepatic function, with the Modified Diet Renal Disease (MDRD) and Chronic Kidney Disease-Epidemiology (CKD-EPI) formulae being more accurate for estimating renal function in relation to hepatic function 2.
- Pharmacologic agents, procedures (such as transjugular intrahepatic portosystemic shunt and renal replacement therapy), and simultaneous liver-kidney transplantation are common therapies used to manage renal failure in end-stage liver disease 4.